Watchlist 5/26/22 & Recap
Happy Wednesday,
Hope you all had a good Wednesday. Yesterday and the other week’s swing setups paid off today for me. I had to stop myself out of GOVX due to an offering dropping mid day since it broke all support levels. It’s the first time I’ve ever had an offering drop in the middle of the day while I was busy at work, so I had no choice but to take a big loss, but it’s all a part of trading; onto the next. Tomorrow, we continue to manage our risks and stick to our own trading plans. May all your accounts be blessed.
Manage Risks & Trading Plan Disclosure
- These are my trading plans, and many ask if I’m holding this or that. If it breaks any of the dip zones that I mention or if it breaks the trend line for a swing on the 5D/30D chart, I will respect my rules and I will respect my stop loss and wait for the setup to re-enter.
- Never bag hold, never average down on a loser UNLESS you’re confident it will reverse, and never turn a day trade into a swing if you do not have a set plan.
- For those under PDT, be careful with setting up swings too early in the day; I prefer waiting until after lunch (EST) to set my swings up (unless it hit my perfect dip zone).
- Always make sure you have a day trade available in case you need to exit and reposition.
- It’s okay to be wrong, but it’s not okay to stay wrong. Hope doesn’t make us money; proper risk management does.
- Many of these are great long term plays if one was to load up on red days while respecting the trend line for setting up swings. There’s nothing wrong with buying on green days if buying the BIG pullbacks. Best way to get burned is to chase while they’re ripping upward.
- If these don’t run yet, and are holding new support levels, especially at my dip zone, assume I’m accumulating, and holding for a bigger move. I mainly set swings up as soon as I see signs of a reversal with anticipation of catalysts. From the original alert, expect my multi-week swings to run at least 100% with pullbacks in-between.
- I provide my watchlists for all types of traders. If you’re conservative, consider anything $50 and up; if you have higher risk tolerance, consider penny stocks below $2; if you’re in the middle, consider anything between $2-$50.
- When trading large caps, it is normal for it to move ~0.5-6%. When trading mid caps, it is normal for it to move ~5-15%. When trading small caps, it is normal for it to move ~8-30%+. When assessing goals, it’s important to make sure to take in consideration a stock’s volatility and match it to your particular trading style.
- SSR triggered setups are my preferred setups for swinging. This does not mean that it cannot be shorted. If the volume is high, price action/momentum is there, with upcoming catalysts; then this is my preferred setup as someone who swings. I keep a mental stop in case I need to reposition my swing. Not every SSR trade will move up; there are many variables one must take into account when trading this type of setup.
- I do NOT hold all stocks listed below. I provide a list of top mentions/trending/abnormal volume movers/upcoming catalysts/earnings/conservative large caps. You decide what you trade based on your preference.
5/26/22 Main Watch
If the market is red, consider respecting your stop losses. Stopping out doesn’t mean you’re unable to re-enter; it’s you giving yourself the best setup while managing your risks, and maximizing profit potential. Waiting for confirmation is crucial once it hits the dip zones; I would never just jump in and buy. It’s important they hold at the dip zone levels. If it breaks below, I typically wait for it to reclaim that dip zone before scaling in.
Refer to the Setups Recap for the swing setups from previous weeks as most of the catalysts are happening this week.
- BKSY
- NILE
- VGFC
- VERU
- CBIO
- BTTX
- RDBX
- GME
- AMC
- BBIG, SSR on
- IGEX (OTC)
BKSY
Day’s Volume: 152,606,832
Average 10 Day Volume: 15.71M
Day’s range: $1.16-$2.97
Closing Price: $2.33
Short Interest: 0.53%
Analyst PT: $6
Catalysts:
- BlackSky Awarded 10-Year Electro Optical Commercial Layer (EOCL) Contract with U.S. Government. 5/25/22. View press release here.
- “Contract with options is valued up to $1.021 billion over the course of the 5-year base period of performance and the five 1-year option periods for imagery from current and future satellite constellations.”
- BlackSky Reports First Quarter 2022 Results. 5/11/22. View press release here.
- First Quarter Financial Highlights:
- Record revenue of $13.9 million, up 91% from prior year period
- Imagery & software analytical services revenue improves 63% over prior year’s quarter
- Net loss of $20.0 million
- Adjusted EBITDA loss of $9.5 million
- Cash balance at the end of March 2022 was $138.4 million
- Capital expenditures of $13.4 million
- First Quarter Financial Highlights:
- 424B3 – Prospectus filed pursuant to Rule 424(b)(3). 05/25/22. View sec-filing here.
- 8-K/A – Current report filing. 5/25/22. View sec-filing here.
- 424B3 – Prospectus filed pursuant to Rule 424(b)(3). 05/25/22. View sec-filing here.
- 8-K – Current report filing. 5/25/22. View sec-filing here.
- 4 – Statement of changes in beneficial ownership of securities. 05/12/22. View sec-filing here.
- 424B3 – Prospectus filed pursuant to Rule 424(b)(3). 5/11/22. View sec-filing here.
- 8-K – Current report filing. 5/11/22. View sec-filing here.
- 10-Q – Quarterly report pursuant to Section 13 or 15(d). 5/11/22. View sec-filing here.
- BlackSky to Participate at the 17th Annual Needham Technology and Media Conference. 5/6/22. View press release here.
- 424B3 – Prospectus filed pursuant to Rule 424(b)(3). 5/2/22. View sec-filing here.
- 10-K/A – Annual report pursuant to Section 13 and 15(d). 5/2/22. View sec-filing here.
BKSY was alerted on twitter this morning at $2.01, and it ran up $0.96 (+47.76%) to high of day (HOD) $2.97, closing at $2.33. It pulled back -27.27% to $2.16. If there is a pullback, possible dip zone ($2.37-$2.52). Due to volatility, I will be alerting live on Twitter if it breaks the dip zone. This will be the next leg to claim $3 levels and push above $4.50-$6 levels by end of week.
NILE
Day’s Volume: 15,571,908
Average 10 Day Volume: 19.83M
Day’s range: $0.27-$0.3295
Closing Price: $0.3090
Short Interest: 4.55%
Analyst PT: High PT: $6.25, Low PT: $4.00, Average PT: $5.13
Catalysts:
- Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3. 5/25/22. View sec-filing here.
- BitNile Holdings Reports Q1 2022 Financial Results, Including Revenue of $33 Million, up 148% From the Prior First Fiscal Quarter. 5/23/22. View press release here.
- BitNile Holdings Announces its Subsidiary, BitNile, Inc., Now Owns 100% of Alliance Cloud Services, LLC, Which Owns and Operates the 617,000 Square Foot Michigan Data Center. 5/12/22. View press release here.
- BitNile Holdings Reports Preliminary Q1 2022 Financial Results Including Revenue of Approximately $32 Million, up 142% From the Prior First Fiscal Quarter. 05/9/22. View press release here.
- BitNile Holdings Issues April Bitcoin Production and Mining Operation Report. 05/2/22. View press release here.
NILE was alerted on twitter on 5/12/22, and now BitNile filed another sec-filing on 5/25/22, so I’m anticipating news in the coming weeks. NILE ran from low of day $0.27 to high of day $0.3295. If there is a pullback, possible dip zone ($0.2875-$0.3075). We’re at the bottom right now, right now is the time when I would accumulate a full position to swing over the next few weeks.
5/25/22 Setups Recap & Trading Plan
These are all swings so if 1) they do not make any significant moves, 2) news have yet to drop, or 3) they have yet to hit the price targets; that means the swing continues as long as it respects the trend line when swinging.
VERU
VERU broke well below my dip zone ($13.80-$14.20) and faded to a low of day (LOD) $11.80. It will need to reclaim $13 levels for the move back up. We are sitting at the dip zone ($11.59-$11.95). SSR is on 5/25/22.
Day’s Volume: 6,182,002
Average 10 Day Volume: 30.37M
Day’s range: $11.87-$12.90
Closing price: $12.37
Short Interest: 24.06%
Analyst PT: $24-$55, Average PT: $36.50
Veru is consistent with their PRs as you’ll see below. A company that has consistent PRs is one that I keep an eye on because you can depend on them to have strong catalysts when swinging long.
Catalysts:
- Veru to Participate in Fireside Chat at the Jefferies Healthcare Conference on June 8, 2022. 5/25/22. View the full press release here.
- Veru Announces Appointment of Joel Batten to Lead U.S. Infectious Disease Franchise to Focus on Hospitalized COVID-19 Patients. 5/18/22 View the full press release here.
- Veru to Present at the H.C. Wainwright Global Investment Conference on May 24th 2022. 5/17/22. View the full press release here.
- Veru Reports Second Quarter Fiscal 2022 Results and Progress of Sabizabulin for COVID-19 Toward a Request for Emergency Use Authorization. 5/12/22. View the full press release here.
- FDA States that Veru Should Submit Request for Emergency Use Authorization (EUA) Based on Positive Efficacy and Safety Data from the Phase 3 Clinical Study of Sabizabulin in Hospitalized COVID-19 Patients. 5/11/22. View the full press release here.
- FDA Has Granted Veru a Pre-Emergency Use Authorization (EUA) Meeting Date for Positive Sabizabulin Phase 3 COVID-19 Study. 5/2/22. View the full press release here.
- Veru Announces Oral Late-Breaking Presentation of Phase 2 Data of Sabizabulin for the Treatment of Hospitalized Severe COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome at the 32nd European Congress of Clinical Microbiology & Infectious Diseases. 4/25/22. View the full press release here.
- Veru’s Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy. 4/11/22. View the full press release here.
VERU dropped below my dip zone to $11.27 premarket (likely caused by low volume, and sellers selling into the bid because it got bought up instantly), and was able to reclaim the dip zone ($11.59-$11.95) and moved up +$1.31 (+11.30%) to high of day $12.90, then fading and closing at $12.37. If there is a pullback tomorrow, there may be a dip zone at $11.75-$11.87.
RDBX
RDBX fell $0.29 below my dip zone but was able to reclaim my dip zone ($5.19-$5.37) (✓), and from there, it moved $0.36 (6.94%) after dropping news after hours (see above catalysts) and hit high of day (HOD) $5.55 after hours. We are currently sitting at the dip zone, ($5.30-$5.55). SSR is on for Wednesday, 5/25/22.
Day’s Volume: 26,699,602
Average 10 Day Volume: 23.83M
Day’s range: $5.20-$6.94
Closing Price: $6.77
Short Interest: 23.78%
Catalysts:
- Redbox Entertainment Acquires North American Rights to WWII Action-Drama Come Out Fighting. 5/24/22. View press release here.
- DEFA14A Sec-Filing Additional proxy soliciting materials – definitive. 5/13/22. View filing here.
- 10-Q Quarterly report which provides a continuing view of a company’s financial position. 5/13/22. View filing here.
- DEFA14A Additional proxy soliciting materials – definitive. 5/12/22. View filing here.
- DEFA14A Additional proxy soliciting materials – definitive. 5/12/22. View filing here.
- DEFA14A Additional proxy soliciting materials – definitive. 5/12/22. View filing here.
- DEFA14A Additional proxy soliciting materials – definitive. 5/12/22. View filing here.
- DEFA14A Additional proxy soliciting materials – definitive. 5/12/22. View filing here.
- DEFA14A Additional proxy soliciting materials – definitive. 5/12/22. View filing here.
- DEFA14A Additional proxy soliciting materials – definitive. 5/12/22. View filing here.
- 8-K Report of unscheduled material events or corporate event. 5/11/22. View filing here.
- 425 Filing of certain prospectuses and communications in connection with business combination transactions. 5/11/22. View filing here.
- Chicken Soup for the Soul Entertainment to Acquire Redbox, Creating Premier Independent Entertainment Company. 5/11/22. View press release here.
RDBX fell $0.25 below my dip zone but was able to reclaim my dip zone ($5.30-$5.55) (✓), and from there, it moved +$1.64 (+30.94%) and hit high of day (HOD) $6.94, and closing at $6.77. If there is a pullback, there may be a dip zone at ($6.29-$6.48).
AGRI
AGRI hit $0.05 below my dip zone ($2.70-$2.85) at $2.65 (✓), moving +$0.16 (+5.93% after hours, but did not make any significant moves, therefore, the swing continues. We are sitting at the dip zone ($2.70-$2.85). SSR will be on Wednesday, 5/25/22. AGRI needs to reclaim $3.25 levels, consolidate, reclaim $4, and consolidate again, for the next leg to $5.
Day’s Volume: 3,620,850
Average 10 Day Volume: 20.13M
Day’s range: $2.69-$3.06
Closing Price: $3.01
Short Interest: 0.42%
Analyst PT: $5
Catalysts:
- “AgriForce to Present at the H.C. Wainwright Global Investment Conference on May 25th” 5/23/22. View full press release here.
- “AgriFORCE Growing Systems Completes Acquisition of Food Production & Processing IP from Manna Nutritional Group (MNG)” 5/18/22. View full press release here.
- “Quarterly report pursuant to Section 13 or 15(d) (10-Q).” 5/16/22. View sec-filing here.
- “AgriFORCE Growing Systems Provides Update on Acquisition of Delphy, a Leading European Agriculture/Horticulture and AgTech Consulting Firm.” 5/12/22. View the full press release here.
- AgriFORCE is presenting at “Microcap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 17th.” Management is scheduled to present on Tuesday, May 17, 2022 at 3:00 p.m. ET. The presentation will be webcast live and available for replay https://www.webcaster4.com/Webcast/Page/2882/45580. 5/11/22. View the full press release here.
- Agriculture stocks are a very hot sector due to food shortage, food inflation, and plant/farm explosions. Agriforce is one of the main leaders according to what’s trending across discords and most mentions.
AGRI hit $0.07 below my dip zone at $2.63 premarket but reclaimed my dip zone ($2.70-$2.85) (✓), moving +$0.36 (+16.35%) to a high of day $3.06, and closing at $3.01. If there is a pullback, possible dip zone ($2.79-$2.85). AGRI needs to reclaim $3.25 levels, consolidate, reclaim $4, and consolidate again, for the next leg to $5.
AMD
AMD fell below my dip zone ($91.25-$93.50) to a low of day (LOD) $89.62, but was able to reclaim my dip zone at $91.25 (✓) moving up +$1.93 (+2.13%) to $93.18. This was also a result of SPY reversing back up. I’ve mentioned I’ll be swinging this over and over, taking it day by day, until I can long it once we hit the bottom. If there is another pullback, possible dip zone ($90.25-$91.50).
Day’s Volume: 111,771,116
Average 10 Day Volume: 137.47M
Day’s range: $89.52-$93.89
Closing Price: $92.65
Short Interest: 2.07%
Analyst PT: High PT: $200, Low PT: $97, Average PT: $137.91
Catalysts:
- AMD Expands Confidential Computing Presence on Google Cloud. 5/25/22. View press release here.
- AMD Showcases Industry-Leading Gaming, Commercial, and Mainstream PC Technologies at COMPUTEX 2022. 5/23/22. View press release here.
- AMD Chair and CEO Dr. Lisa Su to Keynote at COMPUTEX 2022. 5/20/22. View press release here.
- Statement of changes in beneficial ownership of securities. 5/19/22 View press release here.
- AMD Robotics Starter Kit Kick-Starts the Intelligent Factory of the Future. 5/17/22. View press release here.
- AMD and Qualcomm Collaborate to Optimize FastConnect Connectivity Solutions for AMD Ryzen Processors. 5/17/22. View press release here.
- AMD Enables 4G/5G Radio Access Network Solutions to Support Meta Connectivity Evenstar Program. 5/11/22. View press release here.
- AMD Announces Three New Radeon RX 6000 Series Graphics Cards and First Games Adding Support for AMD FidelityFX Super Resolution 2.0. 5/10/22. View press release here.
- New AMD Ryzen 5000 C-Series Processors Bring Leadership Performance and All-Day Battery Life to Chrome OS. 5/5/22. View press release here.
- AMD Reports First Quarter 2022 Financial Results. 5/3/22. View press release here.
AMD fell below my dip zone by $0.73, but reclaimed my dip zone ($90.25-$91.50) (✓), moving +$3.64 (+4.03%) to a high of day (HOD) $93.89.
GOVX
Day’s Volume: 160,847,515
Average 10 Day Volume: 33.04M
Day’s range: $2.23-$3.38
Closing Price: $2.29
Short Interest: 3.60%
Analyst PT: $6
Catalysts:
- GeoVax Receives Notice of Allowance for Cancer Vaccine Patent in China. 5/24/22. View press release here.
- Maxim Group announced a $6 price target for GeoVax. 5/23/22
- “Monkeypox outbreak is primarily spreading through sex, WHO officials say” – CNBC
- GeoVax Announces Upcoming Presentations at Scientific Conferences. 5/4/22. View press release here.
- Pipeline. 5/12/22. View pipeline here.
- 8-K Sec-Filing Current Report. 5/2/22. View filing here.
GOVX hit high of day (HOD) $17.50 premarket, then broke below my dip zone ($1.94-$2.13) but was able to reclaim it at $1.94 (✓), moving up +$1.44 (+74.23%) to high of day (HOD) $3.38. It pulled back -33.73% to my previous dip zone, therefore, we are sitting at the new dip zone level ($2.13-$2.30). If we are able to trigger SSR at $2.06, that price will need to have heavy buying volume pour in for a bullish move up. Once $2.74 levels are reclaimed, and $3 levels are reclaimed, once there is consolidation about $3-$3.25 levels, the move above $4 will come quickly. This is still a multi-day swing to get to the $6 Analyst price target.
GOVX was a swing setup from 5/24/22, but was able to hit my dip zone ($2.13-$2.30) at $2.16 (✓) premarket, and moving +$0.56 (+25.93%) to high of day (HOD) $2.72 intraday. GeoVax then “Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq Rules” mid day, and broke all support levels, hitting low of day $1.45, and closing at $1.67. “The offerings are expected to close on or about May 27, 2022, subject to the satisfaction of customary closing conditions.” If there is any momentum tomorrow, it would be that it is under SSR now.
SIGA
SIGA broke well below my dip zone ($11.06-$11.38) and faded to a low of day (LOD) $8.47, closing at $9.15. It will need to reclaim $10.25 levels for a bullish move back up. We are sitting at the dip zone ($8.85-$9.05). SSR is on 5/25/22.
Day’s Volume: 6,272,205
Average 10 Day Volume: 20.77M
Day’s range: $8.71-$9.46
Closing Price: $8.80
Short Interest: 3.69%
Catalysts:
- SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX® (tecovirimat). 5/19/22. View press release here.
- New Contract Awarded by U.S. Department of Defense for the Procurement of up to Approximately $7.5 Million of Oral TPOXX®. 5/12/22. View press release here.
- SIGA Reports Financial Results for Three Months Ended March 31, 2022. 5/5/22. View press release here.
- SIGA Declares Special Dividend of $0.45 Per Share. 5/5/22. View press release here.
SIGA hit $0.10 below my dip zone but reclaimed the dip zone ($8.85-$9.05) $8.75 (✓) and moved up +$0.71 (+8.11%) to a high of day $9.46. It will need to reclaim $10.25 levels for a bullish move back up. If there is a pullback, possible dip zone ($8.36-$9.51).
Others to Watch/Trending
- AMD
- TSLA
- GFAI
- IMMX
- SKYH
- IDRA
- CBIO
- SOFI
- MNKD
- SOPA
- BBI
- SNMP
- HLVX
- PTGX
Oil/Gas Stocks to Watch for a Reversal
If trading oil, make sure you’re monitoring crude oil prices. Load up on red days. If you chase the day it runs, be careful as they’re more volatile. Be careful swinging anything that’s been trading under $1 for greater than 30 days due to delisting/delinquency requirements or reverse splits; I’d keep them as day trades if uncertain.
- INDO – 9.11% SI
- HUSA – 6.32% SI
- ENSV – 3.43% SI
- CEI – 9.59% SI
- USWS – 11.58% SI
- MXC – 4.74% SI
- MARPS – 3.20% SI
- IMPP – unknown SI
Earnings
5/26/22
- BABA
- M
- JACK
- COST
- ULTA
- DELL
5/27/22
- BIG
- CGC
- SAFM
- HIBB
- VIOT
- PDD
Many have asked how to support me directly, you can open up a Webull Account with my referral link that’s on the sidebar & homepage or you can donate to my blog below via PayPal. Every bit helps to keep my blogging dream alive. I truly appreciate you taking the time to read.
-Cheers
Disclaimer : This should not be considered investment advice, and should not be used to make investment decisions. Do not buy or sell any stock without conducting your own due diligence. Information on eyelovegains.com is opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts and data provided here are not meant for investment purposes and only serve as examples. We are not liable for any losses you may endure from the buying and selling of stocks or securities within your accounts.